CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 74 enrolled
Drug / intervention
MT-1186 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04481750
NCT04481750Phase 1Completed
CompareCT.gov

Phase I Study of Oral Edaravone in Healthy Adult Males (Single- and Multiple-dose Study)

Tanabe Pharma Corporation·interventional·Posted Jul 22, 2020·Updated May 22, 2026

In Brief

A Phase 1 clinical trial evaluating MT-1186 and MT-1186-matching placebo for Healthy Adult Subjects. Completed, enrolled 74 participants across 1 site.

Detailed Summary

To evaluate the pharmacokinetics safety, and tolerability of single and multiple doses of edaravone solution and suspension in healthy adult males

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Adult Subjects
CountriesJapan
Collaborators--

Timeline

Phase 1CompletedFinished
201820192020202120222023202420252026
First PostedJul 22, 2020
Enrollment StartMar 20, 2018
Primary CompletionAug 3, 2018
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 5.9 years ago

Interventions

MT-1186drug

Solution or suspension

MT-1186-matching placebodrug

Solution or suspension